State Street Global Advisors, the issuer of the XPH ETF, operates as the investment adviser to the fund. As the investment adviser, State Street Global Advisors employs a sampling strategy to track the performance of the S&P Pharmaceuticals Select Industry Index. Established in 1993, State Street Global Advisors has a long-standing reputation in the financial industry, offering a diverse range of investment products and solutions to meet the needs of investors worldwide.
While the S&P Pharmaceuticals Select Industry Index, tracked by the XPH ETF, is not explicitly focused on dividends, investors can still benefit from dividend distributions indirectly through the constituent companies. XPH typically distributes dividends based on the performance and dividend policies of pharmaceutical companies within its portfolio. These distributions may occur periodically and are subject to the individual dividend policies of the companies held by the ETF. Given the nature of the pharmaceutical industry, investors may find XPH appealing for potential capital appreciation alongside some level of dividend income.
Tracking the S&P Pharmaceuticals Select Industry Index is the primary objective of the XPH ETF. XPH employs a sampling strategy, allowing flexibility in holding a subset of securities from the index while maintaining similar risk and return characteristics. With a focus on the pharmaceuticals segment of the S&P Total Market Index, XPH provides investors exposure to a specific niche within the healthcare industry. Its portfolio composition may vary based on factors like asset size and market conditions, ensuring alignment with the index's performance. As of July 31, 2023, the Index comprised 38 stocks, reflecting the dynamics of the pharmaceuticals sector within the broader equity market.
The correlation aspect of the SPDR S&P Pharmaceuticals ETF (XPH) provides insights into how this ETF moves in relation to the pharmaceutical sector. As XPH aims to track the performance of the S&P Pharmaceuticals Select Industry Index, its correlation with pharmaceutical stocks is significant. This correlation makes XPH a valuable tool for investors seeking exposure to the pharmaceutical industry and analyzing its performance within the broader market context.
The XPH Pharmaceuticals Sector ETF focuses on tracking the performance of the S&P Pharmaceuticals Select Industry Index. This index includes companies within the pharmaceuticals sub-industry that meet specific criteria related to market capitalization, liquidity, and U.S. domicile. The ETF employs a sampling strategy, allowing it to hold a subset of securities from the index to mirror its risk and return characteristics. With approximately 38 stocks in its portfolio as of July 31, 2023, this ETF provides investors exposure to the pharmaceutical sector, which plays a crucial role in healthcare innovation and therapeutics development. Additionally, the ETF may invest in equity securities not included in the index and utilize derivatives like futures contracts to manage performance and cash flows effectively.
The exposure characteristic of the SPDR S&P Pharmaceuticals ETF (XPH) primarily revolves around the pharmaceutical sector within the U.S. equity market. As it seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, XPH concentrates its holdings in pharmaceutical companies, offering investors targeted exposure to this specific segment. With a focus on companies with market capitalizations greater than or equal to $500 million and U.S.-based operations, XPH ensures a diversified yet focused approach within the pharmaceutical industry. The ETF's holdings may include a subset of securities from the index, providing investors with exposure to key players while managing risk. For deeper insights into XPH's exposure and other US ETFs, ETF Insider's web app offers comprehensive data visualization tools, aiding investors in understanding overlap, correlations, and more.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
4 min readIHE VS XPH are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
4 min readXPH VS pph are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
3 min readPJP VS XPH are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
